F. Fabrizi et al., INFLUENCE OF HEPATITIS-C VIRUS (HCV) VIREMIA UPON SERUM AMINOTRANSFERASE ACTIVITY IN CHRONIC DIALYSIS PATIENTS, Nephrology, dialysis, transplantation, 12(7), 1997, pp. 1394-1398
Background. There are many reports concerning HCV in dialysis patients
and most of them conclude that the clinical and biochemical features
of hepatitis C are often silent in chronic dialysis patients. Elevated
levels of serum alanine aminotransferase activity are a sensitive mea
sure of hepatocellular injury, but so far the relationship between ant
i-HCV and ALT among chronic dialysis patients has been considered impe
rfect. To our knowledge, however, such an issue has not been adequatel
y addressed. Methods. Demographic, biochemical, and virological data f
rom 506 patients undergoing chronic dialysis treatment in four dialysi
s units in Lombardy, northern Italy were collected in order to assess
the influence of virological and host factors on serum aminotransferas
e values. Results. Analysis of covariance showed that positivity for a
nti-HCV antibody was significantly associated with raised serum AST (P
= 0.0001) and ALT (P = 0.0001) levels in the dialysis patients of the
whole study group. Logistic regression analysis performed in the subs
et of patients tested for HCV viraemia and genotype showed that detect
able HCV RNA in serum is a strong predictor of raised AST (P = 0.0001)
and ALT (P = 0.000001) values. Gender showed an independent weak infl
uence on AST levels (P = 0.055), serum levels of ferritin were signifi
cantly (P = 0.042) associated with AST values, the coexistence of HBsA
g infection and positivity for anti-HCV antibody was independently ass
ociated with raised ALT levels (P = 0.016). The other factors (includi
ng positivity for anti-HCV) showed no independent effect on serum amin
otransferase levels when they were matched with HCV viraemia in our mu
ltivariate analysis. HCV RNA positive patients showed serum AST (P<0.0
08) and ALT levels (P<0.0001) higher than HCV RNA negative patients. T
here was no relationship between HCV genotypes and liver enzymes. Conc
lusions. Our data show that detectable HCV RNA in serum is a strong in
dependent predictor of raised aminotransferase values in chronic dialy
sis patients; the relationship between serum aminotransferase values a
nd anti-HCV antibody was exclusively related to the association betwee
n raised aminotransferase values and HCV viraemia; HCV RNA positive pa
tients show higher hepatic enzyme levels than dialysis patients with n
o detectable HCV RNA; no association between HCV genotype and serum am
inotransferase activity was apparent.